Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.82
Delayed Data
As of Jul 22
 -1.66 / -6.78%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.55%
Year-to-Date
Valeant Hits Another Bump
Jul 22 / TheStreet.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Shares Soared Today
Jul 20 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Down on Concerns About Glaucoma Treatment
Jul 22 / TheStreet.com - Paid Partner Content
Valeant's Drug Approvals May Save the Day
Jul 20 / TheStreet.com - Paid Partner Content
Valeant Drug Approval Hampered by FDA Facility Inspection
Jul 22 / TheStreet.com - Paid Partner Content
Jim Cramer -- Valeant Needs These New Drug Approvals
Jul 20 / TheStreet.com - Paid Partner Content
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant (VRX) Stock Gains as FDA Approves Anticonstipation Drug
Jul 20 / TheStreet.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close24.48
Today’s open24.20
Day’s range22.72 - 24.30
Volume23,491,879
Average volume (3 months)34,462,647
Market cap$7.8B
Dividend yield--
Data as of 4:00pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-34.74%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...+0.18+0.19%
JAZZJazz Pharmaceuticals...-1.58-1.10%
RDYDr.Reddy's Laborator...+0.01+0.02%
ALKSAlkermes Plc+0.83+1.69%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$1.57
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer, Director &
Senior VP
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs